Clinical trial
STIMEP: Assessment of Subthalamic Nucleus Stimulation in Drug Resistant…
NCT00228371 · University Hospital, Grenoble, Other · Terminated
Key facts
| NCT number | NCT00228371 |
|---|---|
| Title | STIMEP : Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy |
| Official title | Assessment of Subthalamic Nucleus Stimulation in Drug Resistant Epilepsy Associated With Dopaminergic Metabolism Deficit. A Randomized, Double Blind, Controlled Trial. |
| Lead sponsor | University Hospital, Grenoble, Other |
| Collaborators | Ministry of Health, France |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Epilepsy, Drug Resistant |
| Intervention type | Device |
| Interventions | Neurostimulation |
| Enrollment | 4 |
| Start date | Sep 1, 2005 |
| Primary completion | Dec 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Sep 28, 2005 |
| Last update posted | May 28, 2015 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: